Facing a vaccine shortage, Health Canada is expected to change the number of doses in a vial of Pfizer-BioNTech vaccine from five to six — but that comes with some logistical challenges. Julia Wong explains.
- Pfizer expects US$15 billion in sales from coronavirus vaccine this year
- Pfizer vaccine label changes could force Canada into global syringe race
- Pfizer’s vaccine shipments to Canada already based on 6 doses per vial